Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

ClinicalTrials.gov ID: NCT00761150

Public ClinicalTrials.gov record NCT00761150. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 1:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-Label Period Followed by a Randomized, Double-blind, Placebo-controlled Study of the Analgesic Efficacy of Extended-release Hydrocodone/Acetaminophen (Vicodin CR) Compared to Placebo in Subjects With Chronic Low Back Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of the study was to test the efficacy of 2 tablets (twice daily) of ABT-712, compared to placebo, administered over a 4-week period in participants with moderate to severe mechanical chronic low back pain (CLBP).

Study identification

NCT ID
NCT00761150
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie (prior sponsor, Abbott)
Industry
Enrollment
308 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
21 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2008
Primary completion
Feb 28, 2009
Completion
Feb 28, 2009
Last update posted
Feb 6, 2014

2008 – 2009

United States locations

U.S. sites
32
U.S. states
13
U.S. cities
29
Facility City State ZIP Site status
Site Reference ID/Investigator# 10143 Tempe Arizona 85282
Site Reference ID/Investigator# 10161 Tempe Arizona 85282
Site Reference ID/Investigator# 10155 Tucson Arizona 85741
Site Reference ID/Investigator# 10160 Anaheim California 92801
Site Reference ID/Investigator# 10821 Lomita California 90717
Site Reference ID/Investigator# 10152 Clearwater Florida 33765
Site Reference ID/Investigator# 10157 DeLand Florida 32720
Site Reference ID/Investigator# 10142 Oldsmar Florida 34677
Site Reference ID/Investigator# 10147 Pembroke Pines Florida 33024
Site Reference ID/Investigator# 13821 Plantation Florida 33324
Site Reference ID/Investigator# 15821 Chicago Illinois 60611
Site Reference ID/Investigator# 10136 Crestview Hills Kentucky 41017
Site Reference ID/Investigator# 10822 New Orleans Louisiana 70114
Site Reference ID/Investigator# 10140 Shreveport Louisiana 71103
Site Reference ID/Investigator# 10158 Brockton Massachusetts 02301
Site Reference ID/Investigator# 13601 Fall River Massachusetts 02720
Site Reference ID/Investigator# 10162 Wellesley Hills Massachusetts 02481-2106
Site Reference ID/Investigator# 10159 Omaha Nebraska 68134
Site Reference ID/Investigator# 10126 Las Vegas Nevada 89144
Site Reference ID/Investigator# 10156 Cincinnati Ohio 45227
Site Reference ID/Investigator# 10148 Cincinnati Ohio 45242
Site Reference ID/Investigator# 10151 Kettering Ohio 45429
Site Reference ID/Investigator# 10138 Marion Ohio 43302
Site Reference ID/Investigator# 10150 Perrysburg Ohio 43554
Site Reference ID/Investigator# 10141 Dallas Texas 75251
Site Reference ID/Investigator# 10149 El Paso Texas 79902
Site Reference ID/Investigator# 10130 Fort Worth Texas 76135
Site Reference ID/Investigator# 10163 Killeen Texas 76543
Site Reference ID/Investigator# 13201 San Antonio Texas 78209-1744
Site Reference ID/Investigator# 10154 San Antonio Texas 78229
Site Reference ID/Investigator# 10144 Roanoke Virginia 24018
Site Reference ID/Investigator# 10113 Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00761150, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 6, 2014 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00761150 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →